Silvina Raiden1, Inés Sananez2,3, Federico Remes-Lenicov4,5, Julieta Pandolfi2,3, Cecilia Romero1, Leonardo De Lillo1, Ana Ceballos4,5, Jorge Geffner4,5, Lourdes Arruvito2,3. 1. Hospital General de Niños "Pedro de Elizalde". 2. Hospital de Clínicas "José de San Martín", Universidad de Buenos Aires. 3. Instituto de Inmunología, Genética y Metabolismo, CONICET, Universidad de Buenos Aires. 4. Departamento de Microbiología, Facultad de Medicina, Universidad de Buenos Aires, and. 5. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, CONICET, Universidad de Buenos Aires, Argentina.
Abstract
BACKGROUND: Although human airway epithelial cells are the main target of respiratory syncytial virus (RSV), it also infects immune cells, such as macrophages and B cells. Whether T cells are permissive to RSV infection is unknown. We sought to analyze the permissiveness of CD4+ T cells to RSV infection. METHODS: CD4+ and CD8+ T cells from cord blood, healthy young children, and adults were challenged by RSV or cocultured with infected HEp-2 cells. Infection, phenotype, and cytokine production by T cells were analyzed by flow cytometry or enzyme-linked immunosorbent assay. Expression of RSV antigens by circulating CD4+ T cells from infected children was analyzed by flow cytometry, and disease severity was defined by standard criteria. RESULTS: CD4+ and CD8+ T cells were productively infected by RSV. Infection decreased interleukin 2 and interferon γ production as well as the expression of CD25 and Ki-67 by activated CD4+ T cells. Respiratory syncytial virus antigens were detected in circulating CD4+ and CD8+ T cells during severe RSV infection of young children. Interestingly, the frequency of CD4+ RSV+ T cells positively correlated with disease severity. CONCLUSIONS: Respiratory syncytial virus infects CD4+ and CD8+ T cells and compromises T-cell function. The frequency of circulating CD4+ RSV+ T cells might represent a novel marker of severe infection.
BACKGROUND: Although human airway epithelial cells are the main target of respiratory syncytial virus (RSV), it also infects immune cells, such as macrophages and B cells. Whether T cells are permissive to RSV infection is unknown. We sought to analyze the permissiveness of CD4+ T cells to RSV infection. METHODS: CD4+ and CD8+ T cells from cord blood, healthy young children, and adults were challenged by RSV or cocultured with infected HEp-2 cells. Infection, phenotype, and cytokine production by T cells were analyzed by flow cytometry or enzyme-linked immunosorbent assay. Expression of RSV antigens by circulating CD4+ T cells from infected children was analyzed by flow cytometry, and disease severity was defined by standard criteria. RESULTS: CD4+ and CD8+ T cells were productively infected by RSV. Infection decreased interleukin 2 and interferon γ production as well as the expression of CD25 and Ki-67 by activated CD4+ T cells. Respiratory syncytial virus antigens were detected in circulating CD4+ and CD8+ T cells during severe RSV infection of young children. Interestingly, the frequency of CD4+ RSV+ T cells positively correlated with disease severity. CONCLUSIONS: Respiratory syncytial virus infects CD4+ and CD8+ T cells and compromises T-cell function. The frequency of circulating CD4+ RSV+ T cells might represent a novel marker of severe infection.
Authors: Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham Journal: PLoS One Date: 2011-01-28 Impact factor: 3.240
Authors: Sarah Geoghegan; Anabella Erviti; Mauricio T Caballero; Fernando Vallone; Stella M Zanone; Juan Ves Losada; Alejandra Bianchi; Patricio L Acosta; Laura B Talarico; Adrian Ferretti; Luciano Alva Grimaldi; Andrea Sancilio; Karina Dueñas; Gustavo Sastre; Andrea Rodriguez; Fernando Ferrero; Edgar Barboza; Guadalupe Fernández Gago; Celina Nocito; Edgardo Flamenco; Alberto Rodriguez Perez; Beatriz Rebec; F Martin Ferolla; Romina Libster; Ruth A Karron; Eduardo Bergel; Fernando P Polack Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405
Authors: Asuncion Mejias; Blerta Dimo; Nicolas M Suarez; Carla Garcia; M Carmen Suarez-Arrabal; Tuomas Jartti; Derek Blankenship; Alejandro Jordan-Villegas; Monica I Ardura; Zhaohui Xu; Jacques Banchereau; Damien Chaussabel; Octavio Ramilo Journal: PLoS Med Date: 2013-11-12 Impact factor: 11.069
Authors: David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405
Authors: Christopher S Anderson; Tatiana Chirkova; Christopher G Slaunwhite; Xing Qiu; Edward E Walsh; Larry J Anderson; Thomas J Mariani Journal: J Virol Date: 2021-03-17 Impact factor: 5.103
Authors: Elisabeth A van Erp; Puck B van Kasteren; Teun Guichelaar; Inge M L Ahout; Cornelis A M de Haan; Willem Luytjes; Gerben Ferwerda; Oliver Wicht Journal: J Virol Date: 2017-10-13 Impact factor: 5.103
Authors: Yaneisi Vázquez; Liliana González; Loreani Noguera; Pablo A González; Claudia A Riedel; Pablo Bertrand; Susan M Bueno Journal: Front Immunol Date: 2019-06-04 Impact factor: 7.561
Authors: Abhijeet R Sonawane; Liang Tian; Chin-Yi Chu; Xing Qiu; Lu Wang; Jeanne Holden-Wiltse; Alex Grier; Steven R Gill; Mary T Caserta; Ann R Falsey; David J Topham; Edward E Walsh; Thomas J Mariani; Scott T Weiss; Edwin K Silverman; Kimberly Glass; Yang-Yu Liu Journal: Sci Rep Date: 2019-09-25 Impact factor: 4.379
Authors: Elisabeth A van Erp; Dorien Feyaerts; Maxime Duijst; H Lie Mulder; Oliver Wicht; Willem Luytjes; Gerben Ferwerda; Puck B van Kasteren Journal: J Infect Dis Date: 2019-02-15 Impact factor: 5.226